Impaired performance of SARS-CoV-2 antigen-detecting rapid tests at elevated temperatures

Verena Claudia Haage; Edmilson Ferreira de Oliveira-Filho; Andres Moreira-Soto; Arne Kühne; Carlo Fischer; Jilian Sacks; Victor Max Corman; Marcel A. Müller; Christian Drosten; Jan Felix Drexler.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21249314

Documentos relacionados

  1. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
  2. Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro.
  3. Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and related coronaviruses.
  4. Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures.
  5. Superior anti-pulmonary viral potential of Natrialba sp. M6-producing surfactin and C50 carotenoid pigment with unveiling its action modes.
  6. Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models.
  7. Inactivation of Coronaviruses during Sample Preparation for Proteomics Experiments.
  8. Evaluation of Broad Anti-Coronavirus Activity of Autophagy-Related Compounds Using Human Airway Organoids.
  9. Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals.
  10. Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs.